RLBN-1127

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRLBN-1127
Drug Alias NameACQT-1127RLBN-1127
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitorsUric acid transporter 1 inhibitorsEnzymes inhibitors
TargetsUric acid transporter 1EnzymesXanthine dehydrogenase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcquist Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAcquist Therapeutics
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A